Advertisement

Ads Placeholder
Loading...

Innate Pharma S.A.

IPHYFPNK
Healthcare
Biotechnology
$1.37
$-0.78(-36.31%)
U.S. Market opens in 3h 28m

IPHYF News Today: Stay Updated with the Latest Innate Pharma S.A. News in Real Time

Find IPHYF news now at Meyka AI. Stay informed with the latest Innate Pharma S.A. stocks updates, including price news, market analysis, and expert insights.

Sensex Jumps 500+ Points, Nifty 50 Crosses 23,900 on Banking Rally
📅 in about 2 hours

Sensex Jumps 500+ Points, Nifty 50 Crosses 23,900 on Banking Rally

Indian stock markets opened on a strong note today, continuing their recent recovery trend. The mood on Dalal Street turned positive as buying interest returned in banking and financial stocks. The benchmark index Sensex surged more than 500 points in early trade. At the same time, the Nifty 50 crossed the key 23,900 level, showing…

Read more
Swiss Market Index Today, April 10: Oil Slide After Iran Truce in Focus
📅 1 hour ago

Swiss Market Index Today, April 10: Oil Slide After Iran Truce in Focus

Swiss Market Index today: investors watch if the relief rally can extend after an oil price slump linked to an Iran ceasefire report. Key levels, sectors, and tactics for April 10 in Switzerland.

Read more
BSE Sensex Today, April 09: Ceasefire, Oil Slide Fuel 4% Rebound
📅 20 hours ago

BSE Sensex Today, April 09: Ceasefire, Oil Slide Fuel 4% Rebound

BSE Sensex today jumped nearly 4% as a US-Iran ceasefire and Brent crude falls below $95 lifted risk appetite. Get sector moves, key Nifty levels, and strategy now.

Read more
Hang Seng Index Today, April 09: 3% Rally as Iran Truce Reopens Hormuz
📅 22 hours ago

Hang Seng Index Today, April 09: 3% Rally as Iran Truce Reopens Hormuz

Hang Seng Index jumps 3.1% to 25,893 as Iran truce lifts risk appetite and hopes for a Strait of Hormuz reopening. Tech leads with the Hang Seng Tech Index up 5.22%.

Read more
SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026
📅 22 hours ago

SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026

Citigroup initiates Buy coverage on Summit Therapeutics (SMMT) with initial analyst rating, citing scarcity value in competitive drug market.

Read more
SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026
📅 22 hours ago

SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026

Citigroup initiates Buy coverage on Summit Therapeutics (SMMT) with initial analyst rating, citing scarcity value in competitive drug market.

Read more
4506.T Stock Today: April 9 – ¥116.5B Public Offering for R&D, Debt
📅 24 hours ago

4506.T Stock Today: April 9 – ¥116.5B Public Offering for R&D, Debt

Sumitomo Pharma public opening: up to ¥116.49B via 51.3M new shares plus 7.70M OA. Key dates Apr 20–30, dilution math, use of funds, and trading takeaways for Japan investors.

Read more
CHF121.18 Novartis (NOVN.SW) SIX after-hours 08 Apr 2026: most active, analyst signals
📅 1 day ago

CHF121.18 Novartis (NOVN.SW) SIX after-hours 08 Apr 2026: most active, analyst signals

NOVN.SW stock trades CHF121.18 after hours on SIX 08 Apr 2026; volume 3.32M. Meyka AI analysis and forecasts

Read more
April 8: US 100% Drug Tariffs Start July 31; Onshoring Deals in Focus
📅 2 days ago

April 8: US 100% Drug Tariffs Start July 31; Onshoring Deals in Focus

US drug tariffs start on 31 July 2026. Learn how Section 232 tariffs on patented drugs and APIs could affect Singapore costs, supply chains, and investor strategy.

Read more

IPHYF News FAQ